Delivery Order SPE2DR25D3504-SPE2DR26F7CC4
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $5,719.35 to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections. The contract represents a firm fixed price delivery order with a completion date of June 23, 2025, and was competitively awarded without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. This delivery order is...
- The Defense Logistics Agency awarded a $3,214.56 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, non-set-aside contract with a completion date of January 7, 2026, and performance will occur at the company's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor serving federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $4,819.99 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on December 19, 2025. This is a firm fixed price delivery order with an ultimate completion date of December 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price delivery order has a ceiling value of $10,690.57 and an ultimate completion date of October 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injections on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,237.27 by the Defense Logistics Agency on August 13, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and was awarded competitively with no set-aside designation. The award demonstrates the agency's continued reliance on AmerisourceBergen as a critical...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $8,777.80 to supply Zepbound 7.5 mg/0.5 ml pen injections, with an ultimate completion date of April 25, 2025. This firm fixed-price delivery order, awarded on April 24, 2025, represents a non-competitive set-aside purchase and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child award under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injections (0.5 mL units). This competitively awarded, firm fixed-price delivery order carries a ceiling value of $20,677.02 and is scheduled for completion by October 17, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,083.86 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections on September 24, 2025. This contract utilizes firm fixed pricing and was competitively awarded without any set-aside designation. The award was fulfilled by AmerisourceBergen's Corporate Office division, with performance at the company's headquarters in Conshohocken, Pennsylvania. The delivery order is scheduled for completion by September 25,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors at a firm fixed price ceiling value of $5,141.53. This is a non-set-aside, competitively awarded contract with an ultimate completion date of November 18, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7CC4Delivery Order
The Defense Logistics Agency awarded a $12,764.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp (Ultimate UEI: NWEGNLYTBDW4, operating under parent company Cencora, Inc.) on January 6, 2026, for the supply of Zepbound 5 mg/0.5 mL pen injections. The contract, which is a non-set-aside competitive award, carries an ultimate completion date of January 7, 2026, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen's position as a primary pharmaceutical distributor to federal agencies is well-established through its extensive portfolio of medical product deliveries to the Defense Logistics Agency and other government healthcare systems. The Zepbound delivery represents a continuation of the company's critical role in supplying specialty medications, including diabetes treatments, across the Department of Defense supply chain. As a major distributor serving military treatment facilities and veterans' healthcare programs, AmerisourceBergen maintains the capability to fulfill time-sensitive pharmaceutical procurement requirements through its established federal contract infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 1/5/26 |